Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD …

Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD …
NEW ORLEANS, May 21 /PRNewswire-FirstCall/ — Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV(TM) (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), at a major psychiatric meeting.

Read more on redOrbit

More Meth Drug Addiction Info:

• Attention Deficit Hyperactivity Disorder (ADHD) – Drug Pipeline …
• Attention Deficit Disorder and Kids « Steven Thorpe
• HP to offer WebOS smartphones, tablets but not netbooks | Techlogg.com
• How You Can Identify ADHD In Young Girls And Boys | kids-and …
• Attention Deficit Hyperactivity Disorder Treatment | Depression …
• Attention deficit hyperactivity disorder – Treatment, Prevention …
• Homeopathy As An Alternative Medicine For ADHD – ADHD
• Study Data Show INTUNIV(TM) (guanfacine) Extended Release Tablets …
• Intuniv Guanfacine Drug Information | 500 Health
• Melatonin Time Release 90 tabs